OC
SWAV

Oppenheimer & Co’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Oppenheimer & Co’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,987
Closed -$567K – 1485
2023
Q2 		$567K Buy
+1,987
New +$552K 0.01% 923
2022
Q4 		– Sell
-2,087
Closed -$580K – 1451
2022
Q3 		$580K Buy
+2,087
New +$531K 0.01% 838
2022
Q2 		– Sell
-1,816
Closed -$377K – 1560
2022
Q1 		$377K Buy
1,816
+24
+1% +$3.96K 0.01% 1103
2021
Q4 		$320K Buy
+1,792
New +$353K 0.01% 1201

Other funds holding SWAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Oppenheimer & Co's SWAV Position: Q3 2023 in Review

Oppenheimer & Co sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2023, closing a stake of 1,987 shares — an estimated $567K sold.

Oppenheimer & Co first reported a position in SWAV in Q4 2021 and held it in 4 quarters. The position peaked at $580K in Q3 2022. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

  • Oppenheimer & Co reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Oppenheimer & Co sold 1,987 Shockwave Medical, Inc. Common Stock shares in Q3 2023, an estimated $567K.
  • Oppenheimer & Co first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • Oppenheimer & Co's Shockwave Medical, Inc. Common Stock position peaked at $580K in Q3 2022.
  • 412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2023.

Based on Oppenheimer & Co's 13F filing for Q3 2023, filed 8 Nov 2023.